Invacare Corporation (IVC): Price and Financial Metrics
Invacare Corporation (IVC)
Today's Latest Price: $6.04 USD
Updated Jul 9 11:32am
Add IVC to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 132 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
IVC Stock Summary
- IVC's went public 30.31 years ago, making it older than 84.67% of listed US stocks we're tracking.
- IVC's price/sales ratio is 0.24; that's higher than the P/S ratio of only 10.68% of US stocks.
- Over the past twelve months, IVC has reported earnings growth of -97.06%, putting it ahead of only 17.1% of US stocks in our set.
- If you're looking for stocks that are quantitatively similar to Invacare Corp, a group of peers worth examining would be MTW, FLOW, CMT, NP, and ORN.
- Visit IVC's SEC page to see the company's official filings. To visit the company's web site, go to www.invacare.com.
IVC Stock Price Chart Technical Analysis Charts
IVC Price/Volume Stats
| Current price | $6.04 | 52-week high | $11.63 |
| Prev. close | $6.24 | 52-week low | $3.90 |
| Day low | $5.97 | Volume | 61,314 |
| Day high | $6.25 | Avg. volume | 442,288 |
| 50-day MA | $6.63 | Dividend yield | 0.8% |
| 200-day MA | $7.58 | Market Cap | 207.93M |
Invacare Corporation (IVC) Company Bio
Invacare Corporation designs, manufactures, and distributes medical equipment and supplies used in the home and long-term care settings. It operates through four segments: North America/Home Medical Equipment, Institutional Products Group, Europe, and Asia/Pacific. The company was founded in 1885 and is based in Elyria, Ohio.
IVC Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $6.04 | $0.61 | -90% |
Below please find a table outlining a discounted cash flow forecast for IVC, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Invacare Corp ranked in the 12th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. The most interesting components of our discounted cash flow analysis for Invacare Corp ended up being:
- Interest coverage, a measure of earnings relative to interest payments, is -0.01; that's higher than merely 21.23% of US stocks in the Healthcare sector that have positive free cash flow.
- 43% of the company's capital comes from equity, which is greater than merely 24.21% of stocks in our cash flow based forecasting set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -91% |
| 1% | -90% |
| 2% | -90% |
| 3% | -90% |
| 4% | -90% |
| 5% | -90% |
DYNT, IDXX, LCTC, RGEN, and CRY can be thought of as valuation peers to IVC, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
Loading social stream, please wait...